News related to Abilify (Aripiprazole) and/or conditions it is approved for
FDA approves first generic Abilify to treat mental illnesses
Source: Bipolar News From Medical News Today [2015.04.30]
The U.S. Food and Drug Administration has approved the first generic versions of Abilify (aripiprazole).
First Generic Abilify Approved
Source: MedicineNet Bipolar Disorder Specialty [2015.04.30]
Title: First Generic Abilify Approved
Category: Health News
Created: 4/29/2015 12:00:00 AM
Last Editorial Review: 4/30/2015 12:00:00 AM
Results announced from the QUALIFY study in schizophrenia
Source: Schizophrenia News From Medical News Today [2015.03.31]
Otsuka Pharmaceutical Europe Ltd. presented the results of the QUALIFY* study, which showed the superiority of Abilify Maintena compared to paliperidone palmitate when using the Heinrichs-Carpenter...
How a schizophrenia risk gene affects the brain
Source: Genetics News From Medical News Today [2015.05.22]
Scientists have for the first time shown how the disruption of a key gene involved in mental illness impacts on the brain.
FDA OKs 3-Month Paliperidone Injection for Schizophrenia
Source: Medscape Psychiatry & Mental Health Headlines [2015.05.19]
The quarterly treatment for schizophrenia must be preceded by monthly injections of Invega Sustenna for at least 4 months.
Bone Drug Might Help in Schizophrenia (CME/CE)
Source: MedPage Today Psychiatry [2015.05.19]
(MedPage Today) -- Selective estrogen receptor modulator improves cognition, study shows.
Source: MedicineNet Alcohol Abuse and Alcoholism Specialty [2015.05.14]
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 5/14/2015 12:00:00 AM
Advanced MRI scans could help predict people at risk of schizophrenia
Source: MRI / PET / Ultrasound News From Medical News Today [2015.05.12]
New scanning methods which map the wiring of the brain could provide a valuable new tool to predict people at risk of schizophrenia, according to a new study.
Positive top-line results announced from pivotal Phase 3 trial of RBP-7000 in schizophrenia
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.05.07]
Indivior PLC has announced top-line results from its phase 3 clinical trial of RBP-7000, an investigational drug in development for the treatment of schizophrenia.
Scientists reconcile three unrelated theories of schizophrenia
Source: Schizophrenia News From Medical News Today [2015.05.06]
Mouse model will help scientists parse brain-based findingsOveractive neurons in the front of the mouse brain, shown in green, trigger excessive release of the brain chemical dopamine, which...
Study shows INVEGA SUSTENNA effective six months longer than common oral antipsychotics in treatment of schizophrenia
Source: Schizophrenia News From Medical News Today [2015.04.17]
A study published in The Journal of Clinical Psychiatry shows that long-acting INVEGA SUSTENNA® (paliperidone palmitate) was effective six months longer than commonly prescribed oral...
Discovery of communication link between brain areas implicated in schizophrenia
Source: Schizophrenia News From Medical News Today [2015.04.10]
Disruptions are in an inhibitory brain circuit between the thalamus and prefrontal cortexThe CSHL team induced PV interneurons of the medial prefrontal cortex (mPFC) to produce a red...
TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes
Source: Bipolar News From Medical News Today [2015.04.09]
Scientists at The Scripps Research Institute (TSRI) have identified a molecule in the brain that triggers schizophrenia-like behaviors, brain changes and global gene expression in an animal model.
Exercise Might Boost Mental Function in People With Schizophrenia
Source: MedicineNet Schizophrenia Specialty [2015.04.06]
Title: Exercise Might Boost Mental Function in People With Schizophrenia
Category: Health News
Created: 4/3/2015 12:00:00 AM
Last Editorial Review: 4/6/2015 12:00:00 AM
New post-hoc analyses extend understanding of the efficacy and safety of lurasidone in the treatment of schizophrenia
Source: Schizophrenia News From Medical News Today [2015.04.02]
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. have announced the results from three post-hoc analyses evaluating the efficacy and safety of Latuda® (lurasidone) in...
New study found three-month paliperidone palmitate significantly delayed time to relapse in patients with schizophrenia
Source: Schizophrenia News From Medical News Today [2015.04.01]
Three-month paliperidone palmitate, an investigational atypical antipsychotic, significantly delayed time to relapse compared to placebo in patients with schizophrenia, according to a new Phase 3...
An evolutionary approach reveals new clues toward understanding the roots of schizophrenia
Source: Bipolar News From Medical News Today [2015.02.26]
Is mental illness simply the evolutionary toll humans have to pay in return for our unique and superior cognitive abilities when compared to all other species?
Study Finds Need for Improved Schizophrenia Care
Source: MedicineNet olanzapine Specialty [2014.12.04]
Title: Study Finds Need for Improved Schizophrenia Care
Category: Health News
Created: 12/4/2014 12:00:00 AM
Last Editorial Review: 12/4/2014 12:00:00 AM
Schizophrenia and Electroconvulsive Therapy (ECT)
Source: MedicineNet Electroconvulsive Therapy Specialty [2012.02.14]
Title: Schizophrenia and Electroconvulsive Therapy (ECT)
Category: WebMD Second Source
Created: 11/3/2005 12:00:00 AM
Last Editorial Review: 2/14/2012 12:00:00 AM
Zyprexa in schizophrenia shown to prevent brain loss
Source: The Doctors Lounge - Psychiatry
Zyprexa (olanzapine) was found to decrease brain loss in schizophrenia patients according to the Archives of General Psychiatry.
Brandeis researchers identify potential cause of schizophrenic symptoms
Source: Schizophrenia News From Medical News Today [2015.05.11]
Abnormal brain waves may provide drug target for therapeutic treatmentsSchizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.
Mighty microexons take center stage in shaping of the brain
Source: Schizophrenia News From Medical News Today [2015.04.05]
Complex brain disorders, such as autism or schizophrenia, still puzzle scientists because their causes lie hidden in early events of brain development, which are still poorly understood.
With kids' antipsychotic treatment on the rise, study looks at prescriber decision-making
Source: Bipolar News From Medical News Today [2015.03.04]
More kids nationwide are taking medications designed to treat such mental illnesses as schizophrenia and bipolar disorder, and pediatricians and psychiatrists at the University of Vermont want to...